Table 2 Biomarkers phenotyping and clinical characteristics
From: Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study
|  | Phenotype 1 (n = 95) | Phenotype 2 (n = 92) | p-value* |
|---|---|---|---|
Gender, male, n (%) | 65 (68) | 56 (61) | 0.28 |
Age, mean (SD) | 54 (16) | 56 (14) | 0.13 |
Need for mechanical ventilation, n (%) | 32 (34) | 38 (41) | 0.28 |
Thorax CT scan extension of lesions > 50%, n (%) | 36 (38) | 34 (37) | 0.88 |
Charlson comorbidity index, mean (SD) | 1.72 (1.5) | 1.72 (1.6) | 0.50 |
BMI, mean (SD) | 27 (10) | 27 (8) | 0.40 |
SOFA at admission, mean (SD) | 2.98 (2.4) | 3.79 (3.1) | 0.02 |
SAPS III score, mean (SD) | 41 (25) | 47 (24) | 0.11 |
Respiratory SOFA, mean (SD) | 2.04 (1.1) | 2.17 (1.0) | 0.19 |
Non-survivor, n (%) | 18 (19) | 30 (33) | 0.03 |